Skip to main content
Chatchawin Assanasen, MD, Pediatric Hematology & Oncology, San Antonio, TX

ChatchawinAssanasenMDMBA(He/Him)

Pediatric Hematology & Oncology San Antonio, TX

Associate Chief Medical Officer UT Health Physicians Ambulatory Services Professor and Distinguished Chair in Pediatric Oncology UT Health San Antonio Joe R & Teresa Lozano-Long School of Medicine

Dr. Assanasen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Assanasen's full profile

Already have an account?

  • Office

    7703 Floyd Curl Dr
    # MC 7810
    San Antonio, TX 78229
    Phone+1 210-567-7477
    Fax+1 210-564-7466

Summary

  • Chatchawin Assanasen, MD, based in San Antonio, TX, specializes in Pediatric Hematology & Oncology. He completed his residency in Pediatrics and fellowship in Pediatric Hematology/Oncology and holds a BA in Natural Science and an MBA. Dr. Assanasen currently serves as the Chief Medical Officer at The University of Texas Health Science Center at San Antonio and has held multiple leadership roles in both clinical and academic settings. His professional work focuses on conditions such as aplastic anemia and sickle-cell anemia, and he is actively involved in healthcare outcomes research. Dr. Assanasen's publications address topics including genomic profiling and methotrexate toxicity, and he has contributed to research on cultural health practices and healthcare in low-resource settings. He has participated in clinical trials, notably investigating glutamic acid's role in mitigating vincristine-induced nerve damage in pediatric cancer patients.

Education & Training

  • The University of Texas at San Antonio
    The University of Texas at San AntonioMBA, 2019 - 2021
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2000 - 2003
  • U Texas SW Med Sch
    U Texas SW Med Sch2000 - 2003
  • UF SHANDS-JAX
    UF SHANDS-JAX1999 - 2000
  • University of Florida College of Medicine Jacksonville
    University of Florida College of Medicine JacksonvilleResidency, Pediatrics, 1996 - 1999
  • U Florida COM
    U Florida COM1996 - 1999
  • St. George's University School of Medicine
    St. George's University School of MedicineClass of 1996
  • University of Pennsylvania
    University of PennsylvaniaB.A., Natural Science, 1990

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2011 - 2025
  • FL State Medical License
    FL State Medical License 2000 - 2013
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Best Doctor s in America 2016-2018
  • Best Doctors in America 2009-2010, 2013-2015
  • Winner of Resident Hypothesis Driven Research Award Texas Pediatric Society, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation  
    Ranch D, Crowther BR, Arar MY, Assanasen C, Pediatric Transplantation, 1/1/2014
  • Burkholderia cepacia Septicemia in a Pediatric Oncology Patient: A Pharmacotherapy Challenge  
    Durham SH, Lee A, Assanasen C, Ann Pharmacother, 1/1/2012
  • Ifosfamide Neurotoxicity in Pediatric Patients: A Multi-Institutional Case Series Report  
    Lee A, Henry DW, Ng JS, Parsons K, Poon BB, Schwartz J, Smith T, Assanasen C, Journal of Hematology Oncology Pharmacy, 1/1/2011
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Challenges in Developing Pediatric Cancer Care in Southern Vietnam. Poster Presentation
    Assanasen C, CoPresenter: Tomlinson, G, Cancer Therapy & Research Center (CTRC) Annual Symposium, UTHSCSA, San Antonio, TX, 1/1/2014
  • Intrathecal Cytarabine as substitution for Intrathecal Methotrexate in the setting of Neurotoxicity
    Lewis S, Thomas PJ, Aune GJ, Assanasen C, Pediatric Blood and Cancer, 1/1/2014
  • Acute Kidney Injury in Pediatric Acute Lymphoblastic Leukemia
    Guo N, Ranch D, Assanasen C, Pediatric Blood and Cancer, 1/1/2014
  • Join now to see all

Lectures

  • Advances in the Diagnosis and Management of aHUS 
    Chicago, IL - 1/1/2014
  • The HUS'es 
    UTHSCSA, San Antonio, TX - 1/1/2014
  • Southeast Asian Pediatric Hematology Oncology Program (UTSEAPHO): A Global Health Initiative. 
    UTHSCSA, San Antonio, TX - 1/1/2014
  • Join now to see all

Press Mentions

  • How Is COVID-19 Taking a Toll on Pediatric Cancer Patients?
    How Is COVID-19 Taking a Toll on Pediatric Cancer Patients?March 5th, 2021
  • University Hospital Pediatric Doctors Treating New Subtype of Leukemia
    University Hospital Pediatric Doctors Treating New Subtype of LeukemiaMarch 1st, 2017

Professional Memberships

Other Languages

  • Thai